Why the study?
Do clinical, echocardiographic, and biochemical variables predict 30-day adverse events in patients with acute pulmonary embolism?
Do clinical, echocardiographic, and biochemical variables predict 30-day adverse events in patients with acute pulmonary embolism?
A simple prognostic score based on clinical findings, BNP, and echocardiography can accurately stratify the short-term risk of adverse outcomes in patients with acute pulmonary embolism.
Answers are grounded in this paper and cite their sources.
May aid short-term risk stratification in acute PE; leaves open prospective validation before clinical adoption.
Rationale: The short-term prognosis of pulmonary embolism (PE) depends on hemodynamic status and underlying disease. The prognostic value of right ventricular dysfunction and injury is less well established.: To evaluate prognostic factors of PE in a multicenter prospective cohort study.: Echocardiography, brain natriuretic peptide (BNP), N-terminal-proBNP and cardiac troponin I measurements were done on admission of 570 consecutive patients with an acute PE. A predictive model was based on independent predictors of 30-day adverse events defined as death, secondary cardiogenic shock, or recurrent venous thromboembolism. and Main Results: At 30 days, 42 patients (7.4%; 95% confidence interval [CI], 5.5-9.8%) had adverse events. On multivariate analysis, altered mental state (odds ratio [OR] 6.8; 95% confidence interval [CI], 2.0-23.3), shock on admission (OR 2.8; 95% Cl, 1.1-7.5), cancer (OR 2.9; 95% Cl, 1.2-6.9), BNP (OR 1.3 for an increase of 250 ng/L; 95% Cl, 1.1-1.6) and right to left ventricle diameter ratio (OR 1.2 for an increase of 0.1; 95% Cl, 1.1-1.4) were associated with 30-days of adverse events. The predictive performance of the model was good (area under receiver operating characteristics curve 0.84 [95% Cl, 0.78-0.90]), making it possible to develop a bedside prognostic score.: BNP and echocardiography may be useful determinants of the short-term outcome for patients with PE, together with clinical findings. Patients with PE can be stratified according to the initial risk of adverse outcome, using a simple score based on clinical, echocardiographic, and biochemical variables.
No takes yet. Share an insight, caveat, or question.
Sanchez et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: